Company intelligence / Profile preview
Biora Therapeutics
San Diego, California, United Statesbioratherapeutics.com ↗
- Ownership
- Public · BIOR
- Development stage
- Other
01
Overview
Biora Therapeutics has developed two main smart-pill drug delivery platforms—BioJet™ for systemic, needle-free oral delivery of large molecules and NaviCap™ for targeted GI tract drug release. The company’s lead programs include an anti-TNF-alpha monoclonal antibody delivered orally for ulcerative colitis and other autoimmune diseases. As of early 2025, the company completed a court-supervised restructuring, emerged as a private entity with new ownership by major investment funds, and continues to advance its platform technologies with ongoing pharma collaborations. Clinical results are not yet publicly detailed.
- Therapeutic areas
- GastroenterologyImmunology
- Modalities
- DeviceBiologicSmall molecule
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Pharma collaborators (names undisclosed)
Beyond the preview
Go deeper on Biora Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biora Therapeutics.